| Not Yet Recruiting | A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Meningioma | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC Extensive-stage Small-cell Lung Cancer | Phase 2 | 2026-04-25 |
| Not Yet Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Partic Healthy Participants | Phase 1 | 2026-02-03 |
| Recruiting | Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma Advanced Pheochromocytoma and Paraganglioma, PCPG | Phase 2 | 2026-01-02 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Focal Seizures | Phase 1 | 2025-11-26 |
| Recruiting | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive HER2-positive Breast Cancer, Breast Cancer | Phase 2 | 2025-09-24 |
| Recruiting | Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse | — | 2025-08-05 |
| Terminated | A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Narcolepsy | Phase 1 | 2025-05-13 |
| Recruiting | Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex | — | 2025-02-24 |
| Recruiting | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors Breast Cancer, Gastric Cancer, Esophageal Cancer | Phase 2 | 2025-01-14 |
| Recruiting | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Metastatic HER2-positive Breast Cancer | Phase 3 | 2024-08-13 |
| Recruiting | Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced Biliary Tract Cancer | Phase 3 | 2024-07-19 |
| Completed | VYxeoS Liposomal Italian Observational Study iN the Real Practice Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Therapy-Related Acute Myeloid Leukemia | — | 2023-12-07 |
| Recruiting | JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastat Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2023-11-07 |
| Completed | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Particip Idiopathic Hypersomnia, Narcolepsy | Phase 4 | 2023-07-27 |
| Withdrawn | A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder Irritability Associated With Autism Spectrum Disorder, Autism Spectrum Disorder, ASD | Phase 2 | 2023-06-30 |
| Active Not Recruiting | A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Particip Tuberous Sclerosis Complex Associated Neuropsychiatric Disease | Phase 4 | 2023-06-29 |
| Completed | A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Na Narcolepsy | Phase 4 | 2023-06-26 |
| Recruiting | Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sa Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma | Phase 1 / Phase 2 | 2023-05-23 |
| Active Not Recruiting | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting Seizures | — | 2023-04-17 |
| Completed | A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Hea Healthy Participants | Phase 1 | 2023-01-26 |
| Recruiting | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) H3 K27M, Glioma | Phase 3 | 2023-01-23 |
| Terminated | A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2022-12-19 |
| Completed | A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease Parkinson Disease, Tremor | Phase 2 | 2022-12-01 |
| Completed | A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-dep Healthy Participants | Phase 1 | 2022-11-28 |
| Terminated | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures Seizures Associated With EMAS | Phase 3 | 2022-10-31 |
| Recruiting | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitog Advanced Cancer, Metastatic Cancer, Solid Tumor | Phase 1 | 2022-10-10 |
| Terminated | Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Cancer | Phase 2 | 2022-03-03 |
| Completed | CPX-351 Real-World Effectiveness and Safety Study Acute Myeloid Leukemia | — | 2022-01-14 |
| Completed | A Study of JZP150 in Adults With Posttraumatic Stress Disorder Post Traumatic Stress Disorder | Phase 2 | 2021-12-29 |
| Completed | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essenti Essential Tremor | Phase 2 | 2021-12-06 |
| Active Not Recruiting | A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-posit Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma | Phase 3 | 2021-12-02 |
| Completed | A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer HER2-expressing Cancers | Phase 1 / Phase 2 | 2021-09-15 |
| Terminated | Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants Wit Spasticity With Multiple Sclerosis | Phase 3 | 2021-08-16 |
| Active Not Recruiting | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Sol Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex | Phase 4 | 2021-07-07 |
| Completed | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Canc Extensive-stage Small-cell Lung Cancer | — | 2021-06-28 |
| Completed | Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Autism Spectrum Disorder | Phase 2 | 2021-05-31 |
| Terminated | Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (T Seizure in Participants With Tuberous Sclerosis Complex, Seizure in Participants With Dravet Syndrome, Seizure in Participants With Lennox-Gastaut Syndrome | Phase 3 | 2021-05-19 |
| Terminated | Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 3 | 2021-04-30 |
| Completed | A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy Narcolepsy | — | 2021-04-09 |
| Completed | An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy Narcolepsy | Phase 4 | 2021-03-22 |
| Withdrawn | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Post-Traumatic Stress Disorder | Phase 2 / Phase 3 | 2021-02-01 |
| Completed | Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants Spasticity in Participants With Multiple Sclerosis | Phase 3 | 2020-12-21 |
| Recruiting | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms Central Nervous System Neoplasms, Glioblastoma, Gliosarcoma, Adult | Phase 1 | 2020-10-26 |
| Recruiting | Child and Adolescent Registry for Participants With Narcolepsy Narcolepsy | — | 2020-10-10 |
| Terminated | Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due Multiple Sclerosis (MS) | Phase 3 | 2020-10-01 |
| Completed | A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers HER2-amplified Biliary Tract Cancers | Phase 2 | 2020-10-01 |
| Withdrawn | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution Lennox-Gastaut Syndrome | Phase 4 | 2020-10-01 |
| Terminated | Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participant Schizophrenia | Phase 2 | 2020-08-18 |
| Terminated | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure Coronavirus Disease 2019 (COVID-19), Acute Lung Injury, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Phase 2 / Phase 3 | 2020-07-08 |
| Completed | A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Can HER2+/HR+ Breast Cancer | Phase 2 | 2020-06-10 |
| Terminated | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome Rett Syndrome, RTT | Phase 3 | 2020-02-28 |
| Terminated | Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder Autism Spectrum Disorder | Phase 2 | 2020-01-07 |
| Completed | An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lympho Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia | Phase 2 / Phase 3 | 2019-12-27 |
| Completed | A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2019-12-02 |
| Withdrawn | A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease Parkinson's Disease, Tremor | Phase 2 | 2019-12-01 |
| Completed | A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML Acute Myeloid Leukemia | Phase 1 | 2019-10-15 |
| Terminated | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Ne DLBCL, Neurotoxicity Syndromes | Phase 2 | 2019-10-04 |
| Completed | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointes HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | Phase 2 | 2019-08-29 |
| Terminated | Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome Rett Syndrome, RTT | Phase 3 | 2019-07-29 |
| Withdrawn | Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia Adenovirus | Phase 2 | 2018-12-15 |
| Completed | A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With Idiopathic Hypersomnia | Phase 3 | 2018-11-27 |
| Completed | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 | 2018-11-20 |
| Completed | A Post-Marketing Observational Study of VYXEOS™ Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Therapy-Related Acute Myeloid Leukemia | — | 2018-10-23 |
| Terminated | ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer Endometrial Cancer Recurrent | Phase 2 | 2018-03-21 |
| Completed | CX-8998 for Absence Seizures Epilepsy | Phase 2 | 2018-02-25 |
| Completed | An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) Graft-versus-host Disease, Acute-graft-versus-host Disease | Phase 2 | 2018-02-21 |
| Terminated | ONC201 in Pediatric H3 K27M Gliomas Diffuse Intrinsic Pontine Glioma, Glioma, Malignant | Phase 1 | 2018-01-25 |
| Terminated | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation Adenovirus | Phase 2 | 2017-12-22 |
| Terminated | ONC201 in Adults With Recurrent H3 K27M-mutant Glioma Glioma | Phase 2 | 2017-10-30 |
| Completed | A Phase 2 RCT Study of CX-8998 for Essential Tremor Essential Tremor | Phase 2 | 2017-08-29 |
| Completed | Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) Infantile Spasms | Phase 3 | 2017-05-12 |
| Completed | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) Infantile Spasms | Phase 3 | 2017-04-24 |
| Terminated | Oral ONC201 in Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2017-04-19 |
| Completed | A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Narcolepsy With Cataplexy | Phase 3 | 2017-03-14 |
| Completed | A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate H Excessive Sleepiness, Parkinson Disease | Phase 2 | 2017-01-01 |
| Completed | An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate Epilepsy | Phase 2 | 2016-12-15 |
| Completed | A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With E Epilepsy | Phase 2 | 2016-11-09 |
| Completed | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers HER2-expressing Cancers | Phase 1 | 2016-09-30 |
| Completed | Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-O Veno-occlusive Disease | Phase 3 | 2016-09-01 |
| Completed | An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWP Tuberous Sclerosis Complex, Seizures | Phase 3 | 2016-08-31 |
| Completed | Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2016-08-01 |
| Completed | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA Obstructive Sleep Apnea, Excessive Sleepiness | Phase 2 | 2016-07-05 |
| Completed | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolep Narcolepsy, Excessive Sleepiness | Phase 2 | 2016-06-01 |
| Completed | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWP Tuberous Sclerosis Complex, Seizures | Phase 3 | 2016-04-06 |
| Completed | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol Epilepsy | Phase 2 | 2016-03-11 |
| Completed | A Study of GWP42006 in People With Focal Seizures - Part B Epilepsy, Focal Seizures | Phase 2 | 2016-03-01 |
| Completed | A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol Epilepsy | Phase 2 | 2016-01-20 |
| Terminated | Oral ONC201 in Adult Recurrent Glioblastoma Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma | Phase 2 | 2016-01-01 |
| Terminated | A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Cytomegalovirus Disease, Kidney Transplant Infection | Phase 3 | 2015-09-01 |
| Terminated | A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease Cytomegalovirus Disease | Phase 3 | 2015-09-01 |
| Completed | A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy Narcolepsy | — | 2015-07-08 |
| Completed | Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Epilepsy, Lennox Gastaut Syndrome | Phase 3 | 2015-06-08 |
| Completed | "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or O Narcolepsy, Obstructive Sleep Apnea | Phase 3 | 2015-05-01 |
| Completed | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" Obstructive Sleep Apnea | Phase 3 | 2015-05-01 |
| Completed | "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" Obstructive Sleep Apnea | Phase 3 | 2015-05-01 |
| Completed | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcoleps Narcolepsy | Phase 3 | 2015-05-01 |
| Completed | A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Se Epilepsy, Lennox-Gastaut Syndrome | Phase 3 | 2015-04-28 |
| Completed | European VOD Registry Hepatic Veno-Occlusive Disease | — | 2015-04-24 |
| Completed | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adul Epilepsy, Dravet Syndrome | Phase 3 | 2015-04-13 |
| Withdrawn | Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome f Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) | Phase 2 | 2015-04-01 |
| Completed | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) Epilepsy, Dravet Syndrome | Phase 3 | 2015-03-30 |
| Completed | A Study of GWP42006 in People With Focal Seizures - Part A Epilepsy, Focal Seizures | Phase 2 | 2015-03-01 |
| Terminated | A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection t Adenovirus | — | 2015-02-01 |
| Completed | An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects W Healthy Subjects | Phase 1 | 2014-11-01 |
| Completed | A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) Epilepsy, Dravet Syndrome | Phase 2 | 2014-10-22 |
| Withdrawn | An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola Ebola Virus Disease | Phase 2 | 2014-10-01 |
| Withdrawn | An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebol Ebola Virus | Phase 2 | 2014-10-01 |
| Completed | A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Saf Narcolepsy With Cataplexy | Phase 3 | 2014-10-01 |
| Completed | A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastom Cancer | Phase 1 / Phase 2 | 2014-09-01 |
| Terminated | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | 2014-09-01 |
| Completed | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Fo Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) | Phase 2 | 2014-07-01 |
| Withdrawn | An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | Phase 2 | 2014-05-01 |
| Completed | Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infectio Adenovirus Infection | Phase 3 | 2014-03-01 |
| Completed | A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Di Schizophrenia, Schizophrenia-related Psychotic Disorder | Phase 2 | 2014-02-25 |
| Completed | A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes Diabetes Mellitus, Type 2 | Phase 2 | 2014-02-01 |
| Terminated | The Chimerix CMX001 Registry Outcomes, Survival Rates | — | 2014-01-01 |
| Withdrawn | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer Advanced Glioblastoma, Advanced Colorectal Cancer, Advanced Triple-negative Breast Cancer | Phase 1 / Phase 2 | 2014-01-01 |
| Completed | A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2013-12-01 |
| Completed | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Cerebral Palsy | Phase 3 | 2013-12-01 |
| Completed | A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastom Cancer | Phase 1 / Phase 2 | 2013-09-01 |
| Completed | A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects Epilepsy | Phase 1 | 2013-08-01 |
| Completed | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recip CMV | Phase 3 | 2013-08-01 |
| Completed | Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Le Acute Myeloid Leukemia | EARLY_Phase 1 | 2013-08-01 |
| Completed | Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic F Hepatic Impairment | Phase 1 | 2013-07-01 |
| Completed | Patient Registry of Intrathecal Ziconotide Management(PRIZM) Patients With Severe Chronic Pain | — | 2013-07-01 |
| Completed | Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Adenovirus Infections, Human | — | 2013-01-01 |
| Completed | Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute M High Risk Acute Myeloid Leukemia | Phase 3 | 2012-12-13 |
| Completed | A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therap Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | 2012-11-01 |
| Completed | A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcoleps Narcolepsy | Phase 2 | 2012-09-01 |
| Completed | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Adva Pain, Advanced Cancer | Phase 3 | 2012-06-29 |
| Completed | Phase I Study of mPEG-R-Crisantaspase Given IV Hematologic Malignancies | Phase 1 | 2012-03-01 |
| Completed | A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients Multiple Sclerosis, Spasticity | Phase 4 | 2012-01-01 |
| Completed | A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness Narcolepsy | Phase 2 | 2011-12-01 |
| Terminated | Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in M Metastatic Pancreatic Cancer | Phase 2 | 2011-11-01 |
| Completed | Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer Pain, Advanced Cancer | Phase 3 | 2011-05-27 |
| Completed | An Observational Post-Marketing Safety Registry of Sativex® Multiple Sclerosis, Diabetes, Cancer | — | 2011-02-01 |
| Completed | Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects Hepatic Impairment | Phase 1 | 2011-02-01 |
| Completed | Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Unc Pain, Advanced Cancer | Phase 3 | 2011-01-19 |
| Completed | Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruse Double-stranded DNA Virus | Phase 3 | 2010-12-01 |
| Completed | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease Adenovirus Disease | Phase 2 | 2010-11-01 |
| Completed | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes Dyslipidemias, Diabetes Mellitus, Type 2 | Phase 2 | 2010-10-01 |
| Terminated | Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Protein Losing Enteropathy | Phase 1 | 2010-07-01 |
| Completed | A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers Healthy | Phase 1 | 2010-06-01 |
| Completed | Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combinati Fibromyalgia | Phase 3 | 2010-03-01 |
| Completed | CMX001 in Post-transplant Patients With BK Virus Viruria Viruria | Phase 1 / Phase 2 | 2009-11-01 |
| Completed | Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipien Cytomegalovirus Infection | Phase 2 | 2009-10-01 |
| Unknown | Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Oral Mucositis | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 2 | 2009-02-01 |
| Completed | Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers Healthy | Phase 1 | 2008-10-01 |
| Completed | Trial of CPX-351 in Newly Diagnosed Elderly AML Patients Acute Myeloid Leukemia | Phase 2 | 2008-10-01 |
| Withdrawn | A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel Healthy, Anesthesia | Phase 4 | 2008-04-01 |
| Completed | Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor | Phase 1 | 2008-02-01 |
| Completed | Abuse Potential of Sativex Evaluation of Abuse Potential of Sativex | Phase 1 | 2008-02-01 |
| Completed | Study to Assess Food Effect on Sativex Bioavailability Food Effect | Phase 1 | 2008-01-01 |
| Completed | A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, Fro Spasticity, Multiple Sclerosis | Phase 3 | 2008-01-01 |
| Completed | Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures Epilepsy | Phase 2 | 2007-12-01 |
| Completed | Sativex Thorough QT/QTc Study Effects of Sativex on ECG | Phase 1 | 2007-12-01 |
| Completed | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Hepatic Veno-Occlusive Disease | Phase 3 | 2007-12-01 |
| Completed | Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor Essential Tremor | Phase 2 | 2007-12-01 |
| Completed | Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasti Spasticity, Multiple Sclerosis | Phase 3 | 2007-11-01 |
| Terminated | A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2007-04-01 |
| Completed | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropat Pain, Peripheral Neuropathy | Phase 3 | 2007-03-01 |
| Completed | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. Fibromyalgia | Phase 3 | 2006-12-01 |
| Completed | A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. Fibromyalgia | Phase 3 | 2006-12-01 |
| Completed | Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Hematologic Neoplasms | Phase 1 | 2006-09-01 |
| Completed | A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia Fibromyalgia | Phase 3 | 2006-08-01 |
| Completed | Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorect Colorectal Neoplasms | Phase 2 | 2006-07-01 |
| Completed | Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Pa Severe Hepatic Veno-Occlusive Disease | Phase 3 | 2006-07-01 |
| Completed | A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. Pain, Peripheral Neuropathy | Phase 3 | 2005-10-01 |
| Completed | A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia Pain, Peripheral Neuropathy | Phase 3 | 2005-08-01 |
| Completed | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy Pain, Diabetic Neuropathy | Phase 3 | 2005-07-01 |
| Completed | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis Multiple Sclerosis | Phase 3 | 2005-03-01 |
| Completed | A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Diso Anxiety Disorder | Phase 3 | 2005-03-01 |
| Completed | Experimental Medication For the Treatment of Generalized Anxiety Disorder Anxiety Disorder | Phase 3 | 2004-11-01 |
| Completed | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy Narcolepsy | Phase 3 | 2004-10-01 |
| Completed | Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia Fibromyalgia | Phase 2 | 2004-07-01 |
| Completed | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients Obstructive Sleep Apnea Syndrome | Phase 4 | 2003-11-01 |
| Completed | Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Nar Narcolepsy | Phase 3 | 2003-04-01 |
| Completed | A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients Detrusor Overactivity, Multiple Sclerosis | Phase 3 | 2002-08-01 |
| Completed | A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury Pain | Phase 3 | 2002-07-01 |
| Completed | A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. Spasticity, Multiple Sclerosis | Phase 3 | 2002-06-01 |
| Completed | A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. Pain, Peripheral Neuropathy | Phase 3 | 2002-05-01 |
| Completed | Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain Pain, Cancer | Phase 3 | 2002-04-01 |
| Completed | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis Multiple Sclerosis, Neuropathic Pain | Phase 3 | 2002-03-01 |
| Completed | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin Pain, Multiple Sclerosis | Phase 3 | 2002-03-01 |
| Completed | A Study of the Long-term Safety of Sativex Use Multiple Sclerosis, Spasticity, Pain | Phase 3 | 2002-02-01 |
| Completed | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy Palliative Care, Pain, Cancer | Phase 3 | 2002-02-01 |
| Completed | A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pa Pain | Phase 3 | 2001-12-01 |
| Completed | A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Scl Multiple Sclerosis, Spasticity | Phase 3 | 2001-07-01 |
| Completed | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients Multiple Sclerosis | Phase 3 | 2001-05-01 |
| Completed | An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple S Multiple Sclerosis | Phase 3 | 2001-05-01 |
| Approved For Marketing | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML Secondary AML | — | — |
| No Longer Available | An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tr HER2-Positive Advanced Biliary Tract Cancer | — | — |
| No Longer Available | Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas Glioma | — | — |
| Approved For Marketing | A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA Small Cell Lung Cancer | — | — |
| Approved For Marketing | JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | — | — |
| Approved For Marketing | Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas Glioma, H3 K27M | — | — |
| No Longer Available | Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Adenovirus | — | — |
| No Longer Available | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas Glioma | — | — |